Advancing Endovascular Repair for Thoracoabdominal Aortic . . . The TAMBE device is used to offer endovascular treatment for all types of TAAAs and pararenal aneurysms The study will measure the percentage of uncomplicated technical success with the procedure as well as the percentage of participants who do not require significant reintervention for five years
Gore’s Excluder TAMBE Approved by FDA to Treat Complex Aortic . . . January 25, 2024—Gore Associates announced FDA approval for the Excluder thoracoabdominal branch endoprosthesis (TAMBE) The device is an off-the-shelf endovascular solution for the treatment of complex aneurysmal disease involving the visceral aorta
Thoracoabdominal Branch Endoprosthesis (TAMBE) Procedure The Thoracoabdominal Branch Endoprosthesis (TAMBE) procedure is a cutting-edge treatment for complex aortic aneurysms The TAMBE is primarily used for thoracoabdominal aortic aneurysms (TAAA), which is a bulge in the aorta that extends from the chest into the abdomen
New data on TAMBE outcomes in complex aortic aneurysms revealed The US Food and Drug Administration (FDA)-approved Gore Excluder Thoracoabdominal Branch Endoprosthesis (TAMBE) has been shown to be safe and effective at 30 days for the treatment of patients with complex aortic aneurysms involving the visceral aorta
UC Davis Health receives approval for new procedure to treat . . . TAMBE is an implantable, branched endograft device It has four built-in pre-cannulated internal portals to facilitate placement of bridging stent grafts into the visceral arteries perfusing the internal organs within the abdomen